We are live on ! Find out more
SRC

Stone Run Capital Portfolio holdings

AUM $254M
1-Year Est. Return 12.86%
This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+12.86%
3 Year Est. Return
+77.77%
5 Year Est. Return
+98.28%
10 Year Est. Return
+404.21%
AUM
$141M
AUM Growth
-$11M
Cap. Flow
-$4.19M
Cap. Flow %
-2.96%
Top 10 Hldgs %
30.09%
Holding
86
New
1
Increased
12
Reduced
27
Closed
4

Top Buys

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$1.96M
2
FMC icon
FMC
FMC
+$1.4M
3
GNRC icon
Generac Holdings
GNRC
+$1.23M
4
DHR icon
Danaher
DHR
+$275K
5
AMGN icon
Amgen
AMGN
+$228K

Top Sells

Rank Stock Value
1
MCRS
MICROS SYSTEMS INC
MCRS
+$2.34M
2
RRX icon
Regal Rexnord
RRX
+$1.04M
3
CLH icon
Clean Harbors
CLH
+$697K
4
LH icon
Labcorp
LH
+$666K
5
CVE icon
Cenovus Energy
CVE
+$498K

Sector Composition

Rank Sector Weight
1 Industrials 20.22%
2 Materials 19.66%
3 Healthcare 15.87%
4 Energy 13.27%
5 Technology 11.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APD icon
1
Air Products & Chemicals
APD
$65.7B
$5.37M 3.8%
44,591
-2,216
-5% -$271K
SLB icon
2
SLB Ltd
SLB
$73.6B
$4.93M 3.49%
48,524
+2,000
+4% +$218K
FMC icon
3
FMC
FMC
$1.34B
$4.74M 3.35%
95,468
+24,674
+35% +$1.4M
IFF icon
4
International Flavors & Fragrances
IFF
$20.2B
$4.25M 3%
44,275
-4,850
-10% -$490K
DD
5
DELISTED
Du Pont De Nemours E I
DD
$4.14M 2.92%
60,698
-3,686
-6% -$232K
XRAY icon
6
Dentsply Sirona
XRAY
$2.68B
$3.97M 2.81%
87,065
-5,400
-6% -$254K
BCR
7
DELISTED
CR Bard Inc.
BCR
$3.96M 2.8%
27,725
-1,025
-4% -$151K
MHK icon
8
Mohawk Industries
MHK
$7.5B
$3.91M 2.76%
29,000
IHS
9
DELISTED
IHS INC CL-A COM STK
IHS
$3.91M 2.76%
31,195
-50
-0.2% -$6.78K
EW icon
10
Edwards Lifesciences
EW
$49.6B
$3.39M 2.4%
199,350
-150
-0.1% -$2.37K
TMO icon
11
Thermo Fisher Scientific
TMO
$213B
$3.18M 2.25%
26,120
ROP icon
12
Roper Technologies
ROP
$38.8B
$3.1M 2.19%
21,198
-50
-0.2% -$7.35K
MKC icon
13
McCormick & Company Non-Voting
MKC
$13.7B
$3.07M 2.17%
91,800
-200
-0.2% -$6.88K
GNRC icon
14
Generac Holdings
GNRC
$11.6B
$3.06M 2.16%
75,400
+27,400
+57% +$1.23M
DVN icon
15
Devon Energy
DVN
$52.1B
$2.96M 2.09%
43,327
+26,350
+155% +$1.96M
LII icon
16
Lennox International
LII
$14.4B
$2.94M 2.08%
38,300
-975
-2% -$82.4K
DHR icon
17
Danaher
DHR
$137B
$2.93M 2.07%
57,326
+5,356
+10% +$275K
MON
18
DELISTED
Monsanto Co
MON
$2.61M 1.85%
23,200
-1,550
-6% -$181K
BDX icon
19
Becton Dickinson
BDX
$45.6B
$2.56M 1.81%
23,093
ADSK icon
20
Autodesk
ADSK
$49.5B
$2.51M 1.77%
45,474
+200
+0.4% +$11K
PLL
21
DELISTED
PALL CORP
PLL
$2.48M 1.76%
29,700
+2,200
+8% +$180K
CLH icon
22
Clean Harbors
CLH
$16.5B
$2.48M 1.75%
46,025
-11,850
-20% -$697K
PCP
23
DELISTED
PRECISION CASTPARTS CORP
PCP
$2.45M 1.73%
10,350
+600
+6% +$146K
EPAM icon
24
EPAM Systems
EPAM
$5.51B
$2.35M 1.66%
53,750
-3,200
-6% -$127K
HEI icon
25
HEICO Corp
HEI
$49.8B
$2.33M 1.65%
121,704
+10,010
+9% +$209K

Similar funds

Stone Run Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Stone Run Capital held 86 positions worth $141M, down 7.2% from $152M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Stone Run Capital's Q3 2014 filing shows 1 new, 12 increased, 27 reduced and 4 closed positions. Its largest new stake was Amgen: 1,750 shares worth $246K. The largest sale was MICROS SYSTEMS INC, an estimated $2.34M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Materials and Healthcare.

  • Stone Run Capital's largest Q3 2014 buy was Amgen: 1,750 shares worth $246K.
  • Stone Run Capital added most to Devon Energy in Q3 2014, an estimated $1.96M increase.
  • Stone Run Capital's biggest Q3 2014 reduction was Regal Rexnord, cutting an estimated $1.04M.
  • Stone Run Capital fully exited MICROS SYSTEMS INC in Q3 2014, selling an estimated $2.34M.
  • Stone Run Capital's ten largest holdings make up 30% of its $141M portfolio in Q3 2014.
  • Stone Run Capital opened 1 new position and closed 4 in Q3 2014.
  • Stone Run Capital's portfolio value fell 7.2% quarter-over-quarter to $141M.

Based on Stone Run Capital's 13F filing for Q3 2014, filed 14 Nov 2014.